GF
TERN

Gabelli Funds’s Terns Pharmaceuticals TERN Stock Holding History

Gabelli Funds’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-271,857
Closed -$14.3M – 1340
2026
Q1 		$14.3M Buy
+271,857
New +$11.2M 0.1% 256

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's TERN Position: Q2 2026 in Review

Gabelli Funds sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 271,857 shares — an estimated $14.3M sold.

Gabelli Funds first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $14.3M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Gabelli Funds reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Gabelli Funds sold 271,857 Terns Pharmaceuticals shares in Q2 2026, an estimated $14.3M.
  • Gabelli Funds first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Gabelli Funds's Terns Pharmaceuticals position peaked at $14.3M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.